Bruce G. Jenkins

17.8k total citations · 2 hit papers
120 papers, 9.9k citations indexed

About

Bruce G. Jenkins is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bruce G. Jenkins has authored 120 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cellular and Molecular Neuroscience, 37 papers in Molecular Biology and 36 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bruce G. Jenkins's work include Advanced MRI Techniques and Applications (33 papers), Neuroscience and Neuropharmacology Research (29 papers) and Genetic Neurodegenerative Diseases (26 papers). Bruce G. Jenkins is often cited by papers focused on Advanced MRI Techniques and Applications (33 papers), Neuroscience and Neuropharmacology Research (29 papers) and Genetic Neurodegenerative Diseases (26 papers). Bruce G. Jenkins collaborates with scholars based in United States, China and Italy. Bruce G. Jenkins's co-authors include Bruce R. Rosen, M. Flint Beal, Alpaslan Dedeoglu, Ji‐Kyung Choi, Robert J. Ferrante, Walter J. Koroshetz, Neil W. Kowall, Ole Isacson, Ole A. Andreassen and Steven M. Hersch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Bruce G. Jenkins

115 papers receiving 9.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

2002 890 citations Bruce G. Jenkins, Ole Isacson et al. profile →
Regional and progressive thinning of the cortical ribbon in Huntington’s disease

2002 871 citations Bruce G. Jenkins et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce G. Jenkins United States	50	4.7k	4.4k	2.5k	1.7k	1.4k	120	9.9k
Philippe Hantraye France	61	7.0k 1.5×	5.7k 1.3×	3.7k 1.5×	1.3k 0.8×	890 0.6×	199	12.5k
Gerald A. Dienel United States	45	3.6k 0.8×	3.5k 0.8×	965 0.4×	744 0.4×	804 0.6×	120	8.0k
Paola Piccini United Kingdom	60	5.4k 1.1×	2.9k 0.7×	6.5k 2.6×	741 0.4×	1.4k 1.0×	195	11.4k
Eugenii A. Rabiner United Kingdom	56	4.1k 0.9×	3.0k 0.7×	1.3k 0.5×	1.8k 1.0×	1.7k 1.2×	228	10.6k
Sami S. Zoghbi United States	61	6.1k 1.3×	3.6k 0.8×	2.5k 1.0×	2.8k 1.6×	1.8k 1.3×	271	14.2k
Margaret E. Rice United States	55	4.6k 1.0×	3.2k 0.7×	1.4k 0.6×	322 0.2×	1.2k 0.9×	123	9.3k
Hideo Tsukada Japan	47	2.6k 0.6×	2.8k 0.6×	695 0.3×	1.3k 0.7×	1.1k 0.8×	287	8.4k
Denis Guilloteau France	43	2.1k 0.5×	1.9k 0.4×	1.6k 0.7×	1.2k 0.7×	772 0.6×	234	7.6k
Steven M. Hersch United States	55	8.9k 1.9×	8.5k 1.9×	3.7k 1.5×	399 0.2×	952 0.7×	129	12.6k
Raymund A.C. Roos Netherlands	61	8.7k 1.8×	5.5k 1.3×	6.9k 2.8×	764 0.4×	1.1k 0.8×	294	13.1k

Countries citing papers authored by Bruce G. Jenkins

Since Specialization

Citations

This map shows the geographic impact of Bruce G. Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce G. Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce G. Jenkins more than expected).

Fields of papers citing papers by Bruce G. Jenkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce G. Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce G. Jenkins. The network helps show where Bruce G. Jenkins may publish in the future.

Co-authorship network of co-authors of Bruce G. Jenkins

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce G. Jenkins. A scholar is included among the top collaborators of Bruce G. Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce G. Jenkins. Bruce G. Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mealer, Robert G., Bruce G. Jenkins, Chia‐Yen Chen, et al.. (2020). The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation. Scientific Reports. 10(1). 13162–13162. 44 indexed citations

Jenkins, Bruce G., Aijun Zhu, Pekka Poutiainen, et al.. (2015). Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration. Neuropharmacology. 108. 462–473. 9 indexed citations

Korkmaz, Orhan Tansel, Nurgül Aytan, Isabel Carreras, et al.. (2014). 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neuroscience Letters. 566. 286–291. 64 indexed citations

Liu, Christina, et al.. (2014). Data collection and analysis strategies for phMRI. Neuropharmacology. 84. 65–78. 16 indexed citations

Aytan, Nurgül, Ji‐Kyung Choi, Isabel Carreras, et al.. (2013). Combination therapy in a transgenic model of Alzheimer's disease. Experimental Neurology. 250. 228–238. 31 indexed citations

Jenkins, Bruce G.. (2011). Gordon Matta-Clark: Conical Intersect. E-Artexte (Artexte). 2 indexed citations

Choi, Ji‐Kyung, Alpaslan Dedeoglu, & Bruce G. Jenkins. (2010). Longitudinal monitoring of motor neuron circuitry in FALS rats using in-vivo phMRI. Neuroreport. 21(3). 157–162. 3 indexed citations

Choi, Ji‐Kyung, Bruce G. Jenkins, Isabel Carreras, et al.. (2009). Anti-inflammatory treatment in AD mice protects against neuronal pathology. Experimental Neurology. 223(2). 377–384. 49 indexed citations

Astradsson, Arnar, Bruce G. Jenkins, Ji‐Kyung Choi, et al.. (2009). The blood–brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates—Evidence from in vivo neuroimaging studies. Neurobiology of Disease. 35(3). 348–351. 31 indexed citations

10.

McKee, Ann C., Isabel Carreras, Lokman Hossain, et al.. (2008). Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Research. 1207. 225–236. 165 indexed citations

11.

Henchcliffe, Claire, Dikoma C. Shungu, Xiangling Mao, et al.. (2008). Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's Disease. Annals of the New York Academy of Sciences. 1147(1). 206–220. 56 indexed citations

12.

Stack, Edward C., Alpaslan Dedeoglu, Karen Smith, et al.. (2007). Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice. Journal of Neuroscience. 27(47). 12908–12915. 61 indexed citations

13.

Choi, Ji‐Kyung, Alpaslan Dedeoglu, & Bruce G. Jenkins. (2007). Application of MRS to mouse models of neurodegenerative illness. NMR in Biomedicine. 20(3). 216–237. 99 indexed citations

14.

Choi, Ji‐Kyung, et al.. (2004). Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology. 180(4). 705–715. 69 indexed citations

15.

Brownell, Anna‐Liisa, Y. Iris Chen, Meixiang Yu, et al.. (2004). 3‐Nitropropionic acid‐induced neurotoxicity – assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy. Journal of Neurochemistry. 89(5). 1206–1214. 24 indexed citations

16.

Brownell, Anna‐Liisa, et al.. (2003). Neurotoxicity‐Induced Changes in Striatal Dopamine Receptor Function. Annals of the New York Academy of Sciences. 991(1). 281–283. 1 indexed citations

17.

Andreassen, Ole A., Alpaslan Dedeoglu, Robert J. Ferrante, et al.. (2001). Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease. Neurobiology of Disease. 8(3). 479–491. 231 indexed citations

18.

Jenkins, Bruce G., Péter Klivènyi, Ekkehard Küstermann, et al.. (2000). Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice. Journal of Neurochemistry. 74(5). 2108–2119. 139 indexed citations

19.

Brownell, Anna‐Liisa, Wendy R. Galpern, Ole Isacson, et al.. (1999). Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. Neuroreport. 10(14). 2881–2886. 68 indexed citations

20.

Jenkins, Bruce G. & Eduard Kraft. (1999). Magnetic resonance spectroscopy in toxic encephalopathy and neurodegeneration. Current Opinion in Neurology. 12(6). 753–760. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact